biological variation, IVIVC [Dissolution / BCS / IVIVC]

posted by satya – 2007-08-17 18:07 (6534 d 02:35 ago) – Posting: # 989
Views: 7,975

Dear Jamie
I am sorry about my ignorance and naivety in this BA/BE area.
Actually my question was not in context of IVIVC but the interindividual variability in response to formulations (pharmacogenomics context!!!!).
Are bioequivalnce studies supposed to be performed in identical population? (ie. same age, sex, race, ethinicity, pathophysiological condition etc)? For known/unknown reasons there may be differences in PK characteristics of formulations in different populations. If so how much variation is allowed to pass the equivalency test?

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,684 registered users;
91 visitors (0 registered, 91 guests [including 19 identified bots]).
Forum time: 20:43 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5